BioSpace News Archive

Seattle Genetics is claiming certain intellectual property rights related to Daiichi Sankyo’s ADC products.

Bragar Eagel & Squire, P.C., a nationally recognized stockholder law firm, has launched an investigation into whether the board members of Wright Medical Group N.V. breached their fiduciary duties or violated the federal securities laws in connection with the company’s proposed sale to Stryker Corporation..

MiraVista Diagnostics, a global leader in diagnostic testing for fungal diseases, has advanced unprecedented growth in 2019.

Puma Biotechnology, Inc., a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 10:55 a.m. MST on Tuesday, November 12, at the Credit Suisse 28th Annual Healthcare Conference.

All values in this news release are in United States dollars, unless otherwise stated.

Seattle Genetics, Inc. released the following statement in response to Daiichi Sankyo’s filing of a Declaratory Judgment action alleging Seattle Genetics is not entitled to intellectual property rights under a collaboration between the two companies for the development of antibody-drug conjugates

Cosette Pharmaceuticals, Inc., a generic pharmaceutical company primarily focused on extended topical and suppository products, announced today that it has purchased G&W Laboratories’ finished dosage manufacturing plant located in Lincolnton, NC.